Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Niall Redmond .
Filed returns
71
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2024 | Irish Pharmacy Union | Health | Free HRT Budget Announcement (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmacy Union | Health | IPU Pay Claim (Matters involving public funds) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Pfizer | Health | Access to an antiviral medication for the treatment of COVID-19 (Matters involving public funds) | 5 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmacy Union | Health | Department of Health Budget (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Instinctif Partners Public Affairs Ireland | Health | Correspondence to Niall Redmond regarding the arrangement of an in-person meeting. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | EU Commission proposed revision of the EU General Pharmaceutical Legislation and related matters, with particular attention to intellectual property rights provisions, competitiveness and regulatory affairs. (Legislation) | 8 | On lobbying.ie |
| Sep–Dec 2024 | BeLonG To Youth Services Ltd. | Health | Request to meet to discuss the research 'Trans Healthcare in Ireland from Belong To and UCD. (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2024 | Teva Pharmaceuticals Ireland | Health | Difficulties launching generics (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2024 | Irish Pharmacy Union | Health | IPU Pre Budget Submission 2025 (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Follow up to the annual Medicines for Europe 2024 conference 12-13 June in Dublin (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Meeting request regarding the unified position taken by the HSE placing an across-the-board price freeze on all regulated and non-regulated goods and services without giving due consideration to the impact this will… (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Instinctif Partners Public Affairs Ireland | Health | Invitation to the annual Medicines for Europe 2024 conference: 12 - 13 June in Dublin (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2024 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation, particularly items relating to incentives/intellectual property rights; (ii) EU wide access to new medicines. (Legislation) | 10 | On lobbying.ie |
| May–Aug 2024 | Danone Ireland | Health | Letters to eight Designated Public Officials (A Minister of State at the Department of Health, two Assistant Secretaries at the Department of Health, and five members of the Joint Oireachtas Committee on Health)… (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2024 | Ibec | EU Affairs | Poly-fluoroalkylated substances (PFAS) (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Ibec | EU Affairs | European Medical Technologies Regulation (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) | 34 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | (1) Reimbursement process improvements under consideration in the Mazar's Working Group. (2) Delays within Medicines Reimbursement System. (3) Preparation for negotiation of a Framework Agreement in 2025. (4) Process… (Public policy or programme) | 16 | On lobbying.ie |
| May–Aug 2023 | Vulcan Consulting Limited | Health | Rare Disease Policy (Public policy or programme) | 60 | On lobbying.ie |
| Jan–Apr 2023 | Instinctif Partners Public Affairs Ireland | Health | Engagment with the Department with respect to the review of goverance of drug reimbursement processes and recommendations set out in the Mazars Report (published 24/02/23). (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Nursing Homes Ireland | Health | COVID-19 Nursing Homes Expert Panel Recommendations Progress Reports (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 64 | 90.1% | |
| Economic Development and Industry | 5 | 7.0% | |
| EU Affairs | 2 | 2.8% |